Aged Patients Should Benefit from Neuronal Stem Cell Therapy
By LabMedica International staff writers Posted on 28 Jun 2016 |
Image: The hippocampus, located in the medial temporal lobe of the brain (Photo courtesy of Wikimedia Commons).
Neurodegenerative researchers have demonstrated the potential of stem cell therapy for treating elderly individuals with age-related neurological illnesses.
Investigators at the Texas A&M Health Science Center (Temple, Texas, USA) used donor cells from the sub-ventricular zone of the brain to prepare neural stem cells. These stem cells were grafted into the hippocampus of both young and old (the equivalent of about 70 years old in human terms) rats.
Results published in the May 18, 2016, online edition of the journal Stem Cells Translational Medicine revealed that advanced age of the host at the time of grafting had no major adverse effects on engraftment, migration, and differentiation of grafted subventricular zone-neural stem cells (SVZ-NSCs) in the intact hippocampus. Both young and aged hippocampi promoted excellent engraftment, migration, and differentiation of SVZ-NSC graft-derived cells.
In addition, SVZ-NSC grafts established neurogenic niches in non-neurogenic regions, generating new neurons for extended periods after grafting. This phenomenon would be beneficial to transplant recipients if these niches could continuously generate new neurons and glia in the grafted hippocampus, as newly generated neurons and glia would be expected to improve, not only the microenvironment, but also the plasticity and function of the aged hippocampus.
“We are very excited to see that the aged hippocampus can accept grafted neural stem cells as superbly as the young hippocampus does and this has implications for treating age-related neurodegenerative disorders,” said senior author Dr. Bharathi Hattiangady, assistant professor of molecular and cellular medicine at the Texas A&M Health Science Center. “It is interesting that even neural stem cell niches can be formed in the aged hippocampus. What was really exciting is that in both old and young brains, a small percentage of the grafted cells retained their "stemness" feature and continuously produced new neurons. They are still producing new neurons at least three months after implantation, and these neurons are capable of migrating to different parts of the brain.”
Related Links:
Texas A&M Health Science Center
Investigators at the Texas A&M Health Science Center (Temple, Texas, USA) used donor cells from the sub-ventricular zone of the brain to prepare neural stem cells. These stem cells were grafted into the hippocampus of both young and old (the equivalent of about 70 years old in human terms) rats.
Results published in the May 18, 2016, online edition of the journal Stem Cells Translational Medicine revealed that advanced age of the host at the time of grafting had no major adverse effects on engraftment, migration, and differentiation of grafted subventricular zone-neural stem cells (SVZ-NSCs) in the intact hippocampus. Both young and aged hippocampi promoted excellent engraftment, migration, and differentiation of SVZ-NSC graft-derived cells.
In addition, SVZ-NSC grafts established neurogenic niches in non-neurogenic regions, generating new neurons for extended periods after grafting. This phenomenon would be beneficial to transplant recipients if these niches could continuously generate new neurons and glia in the grafted hippocampus, as newly generated neurons and glia would be expected to improve, not only the microenvironment, but also the plasticity and function of the aged hippocampus.
“We are very excited to see that the aged hippocampus can accept grafted neural stem cells as superbly as the young hippocampus does and this has implications for treating age-related neurodegenerative disorders,” said senior author Dr. Bharathi Hattiangady, assistant professor of molecular and cellular medicine at the Texas A&M Health Science Center. “It is interesting that even neural stem cell niches can be formed in the aged hippocampus. What was really exciting is that in both old and young brains, a small percentage of the grafted cells retained their "stemness" feature and continuously produced new neurons. They are still producing new neurons at least three months after implantation, and these neurons are capable of migrating to different parts of the brain.”
Related Links:
Texas A&M Health Science Center
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples